Medtronic (MDT): FY26 Q3 earnings call, Feb 17, 2026
No Kalshi or Polymarket word markets were listed for Medtronic’s Feb 17, 2026 earnings call (FY26 Q3). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
7 matches for “Sphere-9”; 4 quoted, at least 25 words apart.
…this rapidly growing $13-plus billion market with our Affera platform in our Sphere-9 catheter. Our catheters continue to demonstrate leading safety and durability and the…
…indications and geographies to drive continued growth. We are excited to bring Sphere-9 to Japan, and we're pursuing an expanded indication submission in VT. Both…
…around catheters, we believe we have a better portfolio of catheters. Our Sphere-9 is, like I said in the commentary, proven to be quite versatile.…
…And again, that's probably the one catheter that's got more excitement than Sphere-9, and we started the U.S. trial. And then, of course, we're going…
Agents: this page as TSV at /api/v1/appearances/medtronic:2026-02-17:earnings_call · words: /api/v1/brief?appearance=medtronic:2026-02-17:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP